P102 Safety evaluation from an ongoing randomized, double-blind, multiple-ascending dose phase Ib study of enpatoran versus placebo in patients with active systemic or cutaneous lupus erythematosus (SLE/CLE)
oleh: Torsten Witte, Sanjeev Roy, Joerg Wenzel, Nadezda Abramova, Dominika Weinelt, Deborah Denis
| Format: | Article |
|---|---|
| Diterbitkan: | BMJ Publishing Group 2024-03-01 |
Deskripsi
No description available for this item.